Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.
暂无分享,去创建一个
W. Chan | M. Piris | L. Maestre | L. Sánchez-Verde | F. Camacho | S. Montes-Moreno | J. Martínez-Torrecuadrada | G. Roncador | J. Cannata | Yulei Shen | N. Martínez
[1] R. Pike,et al. Molecular characterization of centerin, a germinal centre cell serpin. , 2007, The Biochemical journal.
[2] I. Lossos,et al. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. , 2005, Blood.
[3] Juan F. García,et al. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. , 2003, Haematologica.
[4] J. Benítez,et al. Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas , 2005, Leukemia.
[5] E. Campo,et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.
[6] S. Pileri,et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. , 2005, Blood.
[7] Nerea Martínez,et al. Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively , 2005, The Journal of pathology.
[8] Yasodha Natkunam,et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. , 2004, Blood.
[9] Juan F. García,et al. Aberrant Bcl6 Protein Expression in Mantle Cell Lymphoma , 2004, The American journal of surgical pathology.
[10] M. Piris,et al. Transcriptional Response of T Cells to IFN-α: Changes Induced in IFN-α-Sensitive and Resistant Cutaneous T Cell Lymphoma , 2004 .
[11] D. Mason,et al. Immunofluorescent and FISH Analysis of Skin Biopsies , 2004, The American Journal of dermatopathology.
[12] Ramón Bosch,et al. Building an outcome predictor model for diffuse large B-cell lymphoma. , 2004, The American journal of pathology.
[13] M. Piris,et al. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[14] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[15] S. Pileri,et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. , 2003, Blood.
[16] Juan F. García,et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. , 2003, Blood.
[17] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[18] L. Staudt,et al. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. , 2003, The American journal of pathology.
[19] Robert Tibshirani,et al. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. , 2003, Blood.
[20] A. Dopazo,et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.
[21] Meland,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[22] P. Vyas,et al. Pathology and genetics: Tumours of haematopoietic and lymphoid tissues , 2001 .
[23] O. Kallioniemi,et al. Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.
[24] J. D. Capra,et al. Identification of centerin: a novel human germinal center B cell‐restricted serpin , 2000, European journal of immunology.
[25] Ash A. Alizadeh,et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[27] R. Siebert,et al. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. , 1999, Blood.
[28] B. Nathwani,et al. Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project. , 1999, Human pathology.
[29] P. Koduru,et al. Histiocyte-rich B-cell lymphoma. , 1997, Human pathology.
[30] K. Rajewsky,et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] G. Salvesen,et al. Target Protease Specificity of the Viral Serpin CrmA , 1997, The Journal of Biological Chemistry.
[32] L. McDonald,et al. A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes* , 1996, The Journal of Biological Chemistry.
[33] D. Lawrence,et al. Role of the Catalytic Serine in the Interactions of Serine Proteinases with Protein Inhibitors of the Serpin Family , 1995, The Journal of Biological Chemistry.
[34] J. Delabie,et al. Histiocyte‐Rich B‐Cell Lymphoma: A Distinct Clinicopathologic Entity Possibly Related to Lymphocyte Predominant Hodgkin's Disease, Paragranuloma Subtype , 1992, The American journal of surgical pathology.